focus -WSS

focus

author：leisure time 2025-09-27 12:55:03 - browse：12843

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Mom launches Girl Scout troop for LGBTQ youth in Texas

focus

explore

WSS

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Living organ donors deserve priority status for transplants

Who gets to use the title 'doctor'?

Millions may soon lose Medicaid when they don't have to

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Biden administration plans revamp of organ transplant system

hotspot

focus

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Novo pauses ads for weight loss drug Wegovy amid demand

The high cost of giving birth even with insurance

Biden administration plans revamp of organ transplant system

Medicare details structure of new drug price negotiation program

Bispecific antibodies are next new thing in cancer immunotherapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Xenotransplantation trials will require adjusting expectations, experts say

Apple is now the first public company to be valued at $3 trillion

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

focus

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Can CDC director Mandy Cohen drive consensus in Washington?

Millions may soon lose Medicaid when they don't have to

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

explore

focus

explore

explore